Your browser doesn't support javascript.
loading
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation.
Zhang, CongXiao; Zhu, XinWang; Li, LuLu; Ma, TianKui; Shi, Mai; Yang, Ying; Fan, QiuLing.
Afiliação
  • Zhang C; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
  • Zhu X; Blood Purification Center, Shenyang the 4th Hospital of People, Shenyang 110031, People's Republic of China.
  • Li L; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
  • Ma T; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
  • Shi M; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
  • Yang Y; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
  • Fan Q; Department of Nephrology, The First Hospital of China Medical University, Shenyang 110001, People's Republic of China.
Diabetes Metab Syndr Obes ; 12: 1297-1309, 2019.
Article em En | MEDLINE | ID: mdl-31447572

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article